French biotech company, mainly active in the US market, wants to strengthen its position by going public on Nasdaq
Gain visibility, credibility and raise funds to move to the marketing phase of the new patent
A transitional Finance and Administration Director specializing in IPOs on the US market.
Market share gain in the US: 105% growth in the first year
Louis Dupont, specialist in transition management.Contact us
Connecting good people